Showing results (131-140 of 142) with videos related to
Sort By:
Pageof 15
Arthritis & Rheumatology (Hoboken, N.J.)|December 10, 2023
Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)Elena Pontarini, Elisabetta Sciacca, Farzana Chowdhury, et al.BMJ Medicine|November 3, 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trialKarine Lacombe, Thomas Hueso, Raphael Porcher, et al.Seminars in Arthritis and Rheumatism|March 12, 2021
Characteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tractSégolène Gendreau, Raphael Porcher, Benjamin Thoreau, et al.Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.Radiology|June 29, 2021
Study of Thoracic CT in COVID-19: The STOIC ProjectMarie-Pierre Revel, Samia Boussouar, Constance de Margerie-Mellon, et al.Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.Annals of the Rheumatic Diseases|June 17, 2025
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)Simon J Bowman, Raphaele Seror, Raphael Porcher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic scoreSophie Caillard, Raphael Porcher, François Provot, et al.European Radiology|February 24, 2023
Strategies to safely rule out pulmonary embolism in COVID-19 outpatients: a multicenter retrospective studyGuillaume Chassagnon, Mostafa El Hajjam, Samia Boussouar, et al.Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.Pageof 15